The Juvenile Diabetes Research Foundation said it awarded a three-year, $8 million grant to Animas, a Johnson & Johnson unit, to help it develop an artificial pancreas designed for patients with Type 1 diabetes. The device would feature a glucose sensor that would continuously and wirelessly send data to an insulin pump, which would administer insulin via a patch or a tiny tube.

Related Summaries